GRAIL is a healthcare company innovating to solve healthcare’s most important challenges. Their leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable.

GRAIL's mission is to detect cancer early, when it can be cured. They are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe and effective technologies that can transform cancer screening.

The Galleri test is a first-of-its-kind multi-cancer early detection (MCED) test that can help screen for many of the deadliest cancers that don’t have recommended screening today.